Home/Filings/4/0001179110-19-001564
4//SEC Filing

PASQUALONE FRANK 4

Accession 0001179110-19-001564

CIK 0001583107other

Filed

Feb 6, 7:00 PM ET

Accepted

Feb 7, 5:46 PM ET

Size

6.3 KB

Accession

0001179110-19-001564

Insider Transaction Report

Form 4
Period: 2019-02-05
PASQUALONE FRANK
Sr. VP, Operations
Transactions
  • Award

    Ordinary Shares

    2019-02-05+65,000281,340 total
  • Award

    Ordinary Shares

    2019-02-05+47,250328,590 total
Footnotes (1)
  • [F1]On March 15, 2016, the reporting person was granted a performance stock award that vests based on the achievement of certain performance conditions over a five-year timeframe from 2016 through December 31, 2020 and continued employment. On February 5, 2019, the performance conditions applicable to 47,250 shares were achieved and such shares will vest on February 20, 2020, subject to the reporting person's continued service.

Issuer

Theravance Biopharma, Inc.

CIK 0001583107

Entity typeother

Related Parties

1
  • filerCIK 0001597334

Filing Metadata

Form type
4
Filed
Feb 6, 7:00 PM ET
Accepted
Feb 7, 5:46 PM ET
Size
6.3 KB